CTLA4 and myeloid sarcoma: Attempting to associate genetic CTLA-4 polymorphisms to MS seemed difficult due to the high genetic variability in the population between different country, making it difficult to draw a single picture regarding how CTLA-4 mutations can modulate the onset of MS.